Drug supplies to Canadian pharmacies and distributors are being rationed by pharmaceutical giant AstraZeneca

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An agreement reached with AstraZeneca will allow

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 387, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

AstraZENeca and the A&RT of metadata maintenance

By Frost Paul A A.  

Pharmaceutical Programming, Vol. 3, Iss. 2, 2010-12 ,pp. : 57-63

Maney Publishing

Access to resources Recommend Favorite

Setting Up an Internal Education Programme in Pharmaceutical Medicine: The AstraZeneca `MedEd' Experience

By Sundstedt Carl-David  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 6, 2007-01 ,pp. : 391-394

Adis International

Access to resources Recommend Favorite

Iressa linked to tumour haemorrhage, warns AstraZeneca

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Molecular pathology in oncology – the AstraZeneca perspective

By Campbell David A   Carmichael James   Chopra Rajesh  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1167-1173

Future Medicine

Access to resources Recommend Favorite